Imdelltra Gets Accelerated Approval for Extensive-Stage SCLC
The FDA has granted accelerated approval to Imdelltra (tarlatamab-dlle) for extensive stage small cell lung cancer.
Source: empr.com
Page 3 - Boxed Warning News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Boxed Warning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Boxed Warning Today - Breaking & Trending Today
Tarlatamab Receives Accelerated Approval for Extensive-Stage SCLC
The FDA has approved tarlatamab, a novel bispecific T-cell engager, to treat patients with extensive-cell small cell lung cancer (SCLC).
Source: ajmc.com
FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Breakthrough DLL3-Targeting Therapy Regimen for a Major Solid Tumor
Source: kpvi.com
FDA Approves Amgen's IMDELLTRA?? (Tarlatamab-Llle) for the Treatment of Adult Patients with Extensive-Stage Small Cell Lung Cancer
Amgen announced that the U.S. Food and Drug Administration has approved IMDELLTRA? for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or...
Source: marketscreener.com
Breyanzi Approved for Relapsed/Refractory Follicular Lymphoma
The FDA has granted accelerated approval to Breyanzi (lisocabtagene maraleucel) for the treatment of relapsed or refractory follicular lymphoma.
Source: empr.com